| Literature DB >> 28425074 |
Shaoyun Chen1, Hairong Liang1, Hui Yang1, Kairu Zhou1, Longmei Xu1, Jiaxian Liu1, Bei Lai1, Li Song1, Hao Luo1, Jianming Peng2, Zhidong Liu2, Yongmei Xiao3, Wen Chen3, Huanwen Tang4.
Abstract
In view of the rapid development of gene chips and high-throughput sequencing technology, noncoding RNAs (ncRNas) form a high percentage of the mammalian genome. Two major subgroups of ncRNAs that have been identified are the long ncRNAs (lncRNas) and the microRNAs. A number of studies in the past few years have showed crucial functions for lncRNas in cancer. LincRNa-p21 as a p53-dependent transcriptional target gene and a potential diagnostic marker is involved in proliferation, cell cycle, metabolism and reprogramming. In addition, more researches revealed that lincRNa-p21 is associated with cancer progression and contributed to the treatment and prognosis of cancer. In this review, we briefly summarize the function and molecular mechanisms of lincRNa-p21 in cancer and its regulation for the genes expression .Entities:
Keywords: Cancer; Genes expression; LincRNa-p21; Long noncoding RNAs
Mesh:
Substances:
Year: 2017 PMID: 28425074 DOI: 10.1007/s12032-017-0959-5
Source DB: PubMed Journal: Med Oncol ISSN: 1357-0560 Impact factor: 3.064